Evidence map›Paper›PMID 33709323›Full record

ReviewCurrent HIV/AIDS reports2021

Implementing Implementation Research: Teaching Implementation Research to HIV Researchers.

Sheree R Schwartz, J D Smith, Christopher Hoffmann, Bhakti Hansoti, Sharmistha Mishra, Arianna Rubin Means, Vivian Go, Kenneth Sherr, Denis Nash, Patrick Sullivan and 1 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current HIV/AIDS reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Navigating grey areas in HIV and mental health implementation science.Journal of the International AIDS Society · 2024
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 2 countries.

Sheree R SchwartzDepartment of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD, USA. sschwartz@jhu.edu.ORCID 0000-0001-6090-2880
J D SmithDepartment of Population Health Sciences, University of Utah School of Medicine, Salt Lake City, UT, USA.
Christopher HoffmannJohns Hopkins School of Medicine, Baltimore, MD, USA.
Bhakti HansotiJohns Hopkins School of Medicine, Baltimore, MD, USA.
Sharmistha MishraSt. Michael's Hospital, Li Ka Shing Knowledge Institute, University of Toronto, Toronto, Canada.
Arianna Rubin MeansDepartment of Global Health, University of Washington, Seattle, WA, USA.
Vivian GoDepartment of Health Behavior, Gillings School of Public Health, University of North Carolina, Chapel Hill, NC, USA.
Kenneth SherrDepartment of Global Health, University of Washington, Seattle, WA, USA.
Denis NashInstitute for Implementation Science in Population Health (ISPH), City University of New York (CUNY), New York City, Epidemiology and Biostatistics, Graduate School of Public Health and Health Policy, City University of New York (CUNY), New York City, NY, USA.
Patrick SullivanDepartment of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
Stefan BaralDepartment of Epidemiology, Johns Hopkins School of Public Health, Baltimore, MD, USA.
Johns Hopkins University · USUniversity of Washington · USBloomberg (United States) · USCity University of New York · USEmory University · USSt. Michael's Hospital · CAUniversity of North Carolina at Chapel Hill · USUniversity of Utah · US

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI CONNIE L CELUM · 1988 to 2026
$104.9M
Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Ann M Chahroudi, Colleen F Kelley · 2002 to 2026
$74.0M
Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Anna Palmer Durbin · 2012 to 2026
$67.0M
Virology and Immunology Technology CoreP30AI117943 · NIAID · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Sahera Dirajlal-Fargo · 2015 to 2026
$38.4M
Patient and Population Health Outcomes Research SWGP30AI124414 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI Vinayaka R. Prasad · 2017 to 2026
$28.3M
INNOVATIVE IMPLEMENTATION RESEARCH METHODS COREP30DA027828 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI BROWN, C. HENDRICKS, MUSTANSKI, BRIAN · 2011 to 2020
$11.4M
Examining PrEP use, implementation preferences and the potential for social support to improve PrEP delivery and persistence among female sex workers in Durban, South AfricaR01NR016650 · NINR · JOHNS HOPKINS UNIVERSITY · PI BARAL, STEFAN DAVID · 2016 to 2020
$3.2M
Optimizing PrEP implementation and effectiveness among women at high risk for HIV acquisition in South AfricaR01MH121161 · NIMH · JOHNS HOPKINS UNIVERSITY · PI SCHWARTZ, SHEREE RENAE · 2020 to 2024
$3.1M
NIAID NIH HHS P30 AI027757NIAID NIH HHS P30 AI050409NIAID NIH HHS P30 AI050410NIAID NIH HHS P30 AI094189NIAID NIH HHS P30 AI124414NIDA NIH HHS P30 DA027828NIMH NIH HHS R01 MH121161NINR NIH HHS R01 NR016650
6 · The paper itself

Abstract

purpose of reviewGiven the growth in HIV-related implementation research, there is a need to expand the workforce and rigor through implementation science (IS) training and mentorship. Our objective is to review IS training opportunities for HIV-focused researchers and describe the approach and lessons learned from a recent HIV-related implementation research training initiative. RECENT

findingsIS training opportunities range from degree programs to short- and longer-term professional development institutes and community-focused institutional trainings. Until recently, there have not been extensive dedicated opportunities for implementation research training for HIV-focused investigators. To meet this gap, an inter-Center for AIDS Research IS Fellowship for early-stage investigators was launched in 2019, building on lessons learned from dissemination and implementation training programs. Key components of the HIV-focused IS fellowship include didactic training, mentorship, grant-writing, and development of HIV-IS collaborative networks. Fellows to-date were two-thirds junior faculty and one-third post-doctoral fellows, the majority (69%) with prior public health training. Perceived value of the program was high, with a median rating of 9 [IQR 8-9] on a 10-point scale. Overall, 22/27 (81%) Fellows from the first cohort submitted IS-related grants within 12 months of Fellowship completion, and by 1 year 13 grants had been funded among 10 investigators, 37% overall among Fellows. Mentors identified framing of IS questions as the top-ranked training priority for HIV-investigators. Increasing knowledge of the utility of IS may support more grants focused on optimal implementation of HIV treatment and prevention strategies. Experiences from mentors and trainees engaged in an IS-focused fellowship for HIV investigators demonstrate the demand and value of a dedicated training program and reinforce the importance of mentorship.

Indexed as

HIV InfectionsFellowships and ScholarshipsHumansImplementation ScienceMentorsEarly-stage investigatorsHIVImplementation scienceMentorshipTraining

Identifiers

PMID33709323
OpenAlexW3133600140

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.